(Q58905402)

1

0 references

Ana Paula Duarte de Souza

2

0 references

Luciana Pereira

3

0 references

Megan Smithey

4

0 references

David Hinrichs

5

0 references

Archie Bouwer

6

0 references

Cristina Bonorino

Creative Commons Attribution 3.0 Unported

7

0 references

publication date

2012

0 references

published in

ISRN Immunology

0 references

volume

2012

0 references

page(s)

1-11

0 references

copyright license

start time

25 July 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Tumor immunoediting and immunosculpting pathways to cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Toll-like receptors and immune regulation: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

TLR ligands in the local treatment of established intracerebral murine gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Intradermal administration of lipopolysaccharide in treatment of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Intratumoral injection of lipopolysaccharide causes regression of subcutaneously implanted mouse glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Mechanisms of local immunosuppression in cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Signal 3 availability limits the CD8 T cell response to a solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Initial T cell frequency dictates memory CD8+ T cell lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon gamma and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F926817